References
[1]M. Madkaikar, et al. Current Updates on Classification, Diagnosis and Treatment of Hemophagocytic Lymphohistiocytosis (HLH)[J]. Indian J Pediatr, 2016, 83(5): 434-443
[2]S. Bhushan,N. B. Perumal. Disease associated cytokine SNPs database: an annotation and dissemination model[J]. Cytokine, 2012, 57(1): 107-112
[3]A. P. Kallaur, et al. Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis[J]. Mol Neurobiol, 2017, 54(1): 31-44
[4]M. A. Al-Naseri, et al. Association between interleukin-4 and interleukin-10 single nucleotide polymorphisms and multiple sclerosis among Iraqi patients[J]. Neurol Sci, 2019, 40(11): 2383-2389
[5]Y. H. Chang, et al. Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population[J]. Cytokine, 2006, 36(1-2): 45-50
[6]E. Bergsten, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study[J]. Blood, 2017, 130(25): 2728-2738
[7]Y. Y. Shi,L. He. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci[J]. Cell Res, 2005, 15(2): 97-98
[8]T. Wada, et al. Cytokine profiles in children with primary Epstein-Barr virus infection[J]. Pediatr Blood Cancer, 2013, 60(7): E46-48
[9]Y. Wang, et al. IL-10-592 A/C polymorphisms is associated with EBV-HLH in Chinese children[J]. Hematology, 2016, 21(2): 95-98
[10]P. Yang, et al. Associations between Seven Common Cytokine Gene Polymorphisms and Coronary Artery Disease: Evidence from a Meta-Analysis[J]. Int Arch Allergy Immunol, 2020, 181(4): 301-310
[11]C. A. D. de Lima, et al. Are key cytokines genetic and serum levels variations related to rheumatoid arthritis clinical severity?[J]. Gene, 2020, 722: 144098
[12]M. Lin, et al. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review[J]. Ann Hematol, 2017, 96(8): 1241-1251
[13]J. I. Henter, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48(2): 124-131
[14]Y. Okada, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery[J]. Nature, 2014, 506(7488): 376-381
[15]S. Buhelt, et al. Relationship between Multiple Sclerosis-Associated IL2RA Risk Allele Variants and Circulating T Cell Phenotypes in Healthy Genotype-Selected Controls[J]. Cells, 2019, 8(6)
[16]A. Alcina, et al. IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D)[J]. PLoS One, 2009, 4(1): e4137
[17]X. X. Wang,T. Chen. Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk[J]. Immunol Invest, 2018, 47(5): 431-442
[18]K. Cerosaletti, et al. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients[J]. PLoS One, 2013, 8(12): e83811
[19]C. A. Dendrou, et al. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource[J]. Nat Genet, 2009, 41(9): 1011-1015
[20]Y. Tang, et al. Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome[J]. Br J Haematol, 2008, 143(1): 84-91
[21]R. Posadas-Sánchez, et al. The IL-10-1082 (rs1800896) G allele is associated with a decreased risk of developing premature coronary artery disease and some IL-10 polymorphisms were associated with clinical and metabolic parameters. The GEA study[J]. Cytokine, 2018, 106: 12-18
[22]M. N. Karimabad, et al. Is the IL-10 promoter polymorphism at position -592 associated with immune system-related diseases?[J]. Inflammation, 2013, 36(1): 35-41
[23]J. H. Jung, et al. Association of Interleukin 10 Gene Polymorphisms with Autoimmune Thyroid Disease: Meta-Analysis[J]. Scand J Immunol, 2016, 84(5): 272-277
[24]L. E. Rees, et al. The interleukin-10-1082 G/A polymorphism: allele frequency in different populations and functional significance[J]. Cell Mol Life Sci, 2002, 59(3): 560-569
[25]J. Zheng, et al. IL-10, IL-18 Gene Polymorphisms Might Influence Predisposition to Coronary Artery Disease in East Asians: A Meta-Analysis[J]. Immunol Invest, 2020: 1-10
[26]A. J. Smith,S. E. Humphries. Cytokine and cytokine receptor gene polymorphisms and their functionality[J]. Cytokine Growth Factor Rev, 2009, 20(1): 43-59
[27]M. Pastuszczak, et al. Association of interleukin-10 promoter polymorphisms with serofast state after syphilis treatment[J]. Sex Transm Infect, 2019, 95(3): 163-168
[28]J. Gao, et al. Association of Interleukin-10 Polymorphisms (rs1800872, rs1800871, and rs1800896) with Predisposition to IgA Nephropathy in a Chinese Han Population: A Case-Control Study[J]. Kidney Blood Press Res, 2017, 42(1): 89-98
[29]R. Nasiri, et al. Gene polymorphisms of interleukin-10 and transforming growth factor beta in allergic rhinitis[J]. Allergol Immunopathol (Madr), 2016, 44(2): 125-130
[30]K. R. Engelhardt,B. Grimbacher. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms[J]. Curr Top Microbiol Immunol, 2014, 380: 1-18
[31]M. Korppi, et al. IL-10 gene polymorphism is associated with preschool atopy and early-life recurrent wheezing after bronchiolitis in infancy[J]. Pediatr Pulmonol, 2017, 52(1): 14-20
[32]S. Mohammadi, et al. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population[J]. Int J Immunogenet, 2019, 46(1): 20-30
[33]P. Hong, et al. Associations between genetic polymorphisms in interleukin-10 and hematological oncology: evidence from a meta-analysis[J]. Cancer Biol Ther, 2020, 21(4): 372-378
[34]M. Helminen, et al. Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection[J]. J Infect Dis, 1999, 180(2): 496-499
[35]P. Kapelski, et al. Family-based association study of interleukin 10 (IL10) and interleukin 10 receptor alpha (IL10RA) functional polymorphisms in schizophrenia in Polish population[J]. J Neuroimmunol, 2016, 297: 92-97
[36]A. V. Marangon, et al. Impact of SNPs/Haplotypes of IL10 and IFNG on the Development of Diffuse Large B-Cell Lymphoma[J]. J Immunol Res, 2019, 2019: 2137538
[37]H. D. da Silva, et al. Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus[J]. Mol Biol Rep, 2014, 41(4): 2493-2500
[38]C. J. Li, et al. Correlations of IFN-γ genetic polymorphisms with susceptibility to breast cancer: a meta-analysis[J]. Tumour Biol, 2014, 35(7): 6867-6877
[39]D. Wang, et al. Functional polymorphisms of interferon-gamma affect pneumonia-induced sepsis[J]. PLoS One, 2014, 9(1): e87049
[40]H. Xu,B. Li. Effect of Interferon-γ Polymorphisms on Ankylosing Spondylitis: A Case-Control Study[J]. Med Sci Monit, 2017, 23: 4126-4131
[41]S. E. Löfgren, et al. Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells[J]. J Rheumatol, 2010, 37(3): 574-578
[42]M. Yanagimachi, et al. Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children[J]. J Clin Immunol, 2011, 31(6): 946-951
[43]G. B. Nordang, et al. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts[J]. Rheumatology (Oxford), 2012, 51(4): 619-626
[44]Y. Xu, et al. Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis[J]. Int J Dermatol, 2016, 55(4): 408-416
[45]N. Zhao, et al. Association of inflammatory gene polymorphisms with ischemic stroke in a Chinese Han population[J]. J Neuroinflammation, 2012, 9: 162
[46]J. Javor, et al. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals[J]. J Neurol Sci, 2015, 349(1-2): 138-142
[47]D. Y. Ou, et al. Association of CCR2 gene rs1799864 polymorphism with hemophagocytic lymphohistiocytosis in children[J]. Zhongguo Dang Dai Er Ke Za Zhi, 2015, 17(2): 164-167